{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:19:41Z","timestamp":1761488381015,"version":"3.37.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.clinthera.2009.11.036","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T09:59:17Z","timestamp":1264499957000},"page":"2735-2743","source":"Crossref","is-referenced-by-count":1,"title":["Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: A single-dose, randomized-sequence, open-label, two-period crossover trial"],"prefix":"10.1016","volume":"31","author":[{"given":"Ji-young","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Gyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Sik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ee","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.11.036_bib1","series-title":"The Korean Pharmacopeia","first-page":"761","article-title":"Chlorphenesin carbamate [in Korean]","author":"Hur","year":"2003"},{"journal-title":"Japanese Pharmacopeia","first-page":"356","year":"2001","key":"10.1016\/j.clinthera.2009.11.036_bib2"},{"key":"10.1016\/j.clinthera.2009.11.036_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08869634.1990.11678317","article-title":"Review of oral skeletal muscle relaxants for the craniomandibular disorder (CMD) practitioner","volume":"8","author":"Stanko","year":"1990","journal-title":"Cranio"},{"key":"10.1016\/j.clinthera.2009.11.036_bib4","series-title":"Wilson and Cisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry","first-page":"495","article-title":"Central nervous system depressants","year":"2004"},{"key":"10.1016\/j.clinthera.2009.11.036_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1254\/jjp.36.7","article-title":"Effect of a muscle relaxant, chlorphenesin carbamate, on the spinal neurons of rats","volume":"36","author":"Kurachi","year":"1984","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.clinthera.2009.11.036_bib6","first-page":"329","article-title":"A controlled evaluation of chlorphenesin carbamate in painful musculoskeletal syndromes","volume":"71","author":"Abruzzi","year":"1964","journal-title":"Clin Med (Northfield Il)"},{"key":"10.1016\/j.clinthera.2009.11.036_bib7","first-page":"1451","article-title":"Clinical trial of chlorphenesin carbamate in patients with muscle spasm","volume":"70","author":"Stern","year":"1963","journal-title":"Clin Med (Northfield Il)"},{"key":"10.1016\/j.clinthera.2009.11.036_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-3565(25)26848-3","article-title":"The metabolism of chlorphenesin carbamate","volume":"145","author":"Buhler","year":"1964","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2009.11.036_bib11","series-title":"Ethical Drugs","first-page":"780","article-title":"Drugs in Japan","year":"2006"},{"key":"10.1016\/j.clinthera.2009.11.036_bib12","first-page":"37","article-title":"The subchronic tolerance of chlorphenesin carbamate","volume":"5","author":"Novak","year":"1970","journal-title":"Int Med Dig"},{"key":"10.1016\/j.clinthera.2009.11.036_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1552-4604.1974.tb01366.x","article-title":"Chlorphenesin carbamate serum levels during subchronic administration to human (normal) volunteers","volume":"14","author":"Stoll","year":"1974","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.11.036_bib14","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/jps.2600601121","article-title":"Comparative pharmacokinetics of chlorphenesin carbamate and methocarbamol in man","volume":"60","author":"Forist","year":"1971","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2009.11.036_bib15","first-page":"1313","article-title":"Centrally acting oral skeletal muscle relaxants","volume":"37","author":"Elenbaas","year":"1980","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.clinthera.2009.11.036_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1254\/fpj.70.341","article-title":"Pharmacological studies on a centrally acting muscle relaxant, chlorphenesin carbamate, with special reference to the effect on the motor system [in Japanese]","volume":"70","author":"Fukuda","year":"1974","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1016\/j.clinthera.2009.11.036_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02968581","article-title":"HPLC determination of tolperisone in human plasma","volume":"29","author":"Bae","year":"2006","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.clinthera.2009.11.036_bib20","series-title":"Chlorphenesin Carbamate. 2002 The Standard Protocol of Bioequivalence Tests","first-page":"215","author":"Lee","year":"2003"},{"key":"10.1016\/j.clinthera.2009.11.036_bib22","first-page":"308","article-title":"Analysis of bioequivalence study using a log- transformed model [in Korean]","volume":"44","author":"Lee","year":"2000","journal-title":"Yakhak Hoeji"},{"key":"10.1016\/j.clinthera.2009.11.036_bib23","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.clinthera.2005.10.002","article-title":"Bioavailability of two oral formulations of azithromycin 500 mg: A randomized, openlabel, two-period crossover comparison in healthy Mexican adult subjects","volume":"27","author":"Pinyero-Lopez","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2009.11.036_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2146\/ajhp050490","article-title":"Indentifying drugs needing pharmacogenetic monitoring in a Korean hospital","volume":"64","author":"Kim","year":"2007","journal-title":"Am J Health Syst Pharm"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809004366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809004366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T23:43:28Z","timestamp":1739749408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809004366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0149291809004366"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.11.036","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}